Biotech companies often leverage third-party AI tools to enhance research and operational efficiency. While these tools offer significant benefits, they also introduce potential security risks that must be carefully managed.
Potential Risks of Third-Party AI Tools
- Data Breaches from Misconfigurations: In early 2025, a misconfigured database at DeepSeek exposed over a million sensitive records, highlighting the dangers of inadequate security settings in AI tools .Wikipedia+1Wikipedia+1
- Third-Party Data Leaks: The DM Clinical Research breach exposed 2TB of patient data due to a non-password-protected database, emphasizing the importance of vetting third-party data handling practices .USDM
- Unauthorized Data Sharing: Some AI tools may share data with external entities without proper consent, as seen in cases where user data was transmitted to foreign servers, raising compliance and privacy concerns.
Best Practices for Mitigating Risks
- Conduct Thorough Vendor Assessments: Evaluate the security protocols of AI tool providers, ensuring they meet industry standards and compliance requirements.
- Implement Data Access Controls: Restrict and monitor access to sensitive data within AI tools to prevent unauthorized usage. Reuters+1SentinelOne+1
- Regular Security Audits: Perform ongoing audits of third-party tools to identify and address potential vulnerabilities promptly. USDM
- Establish Clear Data Usage Policies: Define and enforce policies regarding how third-party AI tools can access and use company data.
To effectively manage these risks, biotech firms should consider engaging with an MSSP that specializes in the life sciences sector. Such a partnership provides access to expertise in assessing third-party tools, ensuring that data security and compliance are maintained throughout AI tool integration. USDM
By proactively addressing the security challenges associated with both proprietary AI model development and third-party AI tool usage, biotech companies can safeguard their data assets and maintain trust with stakeholders. Engaging with a specialized MSSP offers a strategic advantage in navigating the complex landscape of AI and big data security.
About Single Point of Contact
Single Point of Contact is an experienced MSP in the biotech industry and is a valuable partner, providing specialized knowledge in implementing robust backup strategies and ensuring network security and stability. With deep understanding of regulatory requirements such as HIPAA and FDA’s 21 CFR Part 11, Single Point of Contact safeguards sensitive research data, clinical trial information, and intellectual property. They offer tailored solutions, including automated backups, real-time monitoring, and disaster recovery plans, minimizing downtime and data loss. By managing security protocols, they protect against cyber threats, allowing biotech companies to focus on innovation while ensuring compliance and uninterrupted operations. This expertise enhances productivity and reduces risk. Contact us today to discover more about how we can help your biotech firm with DR, backup and security.
